Literature DB >> 3342303

The value of testing for unmyelinated fibre, sensory neuropathy in diabetic impotence.

C J Fowler1, Z Ali, R S Kirby, J P Pryor.   

Abstract

Measurement of thermal thresholds provides a means of assessing neurological deficit and in particular of recognising a neuropathic process affecting unmyelinated and small myelinated fibres of the peripheral nerve. These groups of fibres cannot be tested by nerve conduction studies but are particularly susceptible to disease in diabetes. Thresholds for thermal sensation on the sole of the foot were measured in 33 men presenting with erectile dysfunction. All 15 men with erectile dysfunction, which had been considered on clinical grounds to be neuropathic, had abnormal thermal thresholds. Diabetics with non-neuropathic erectile dysfunction had normal results. Whereas tests of unmyelinated sensory fibre function were abnormal in all those with neuropathic erectile dysfunction, electrophysiological measurement of the bulbocavernosus reflex was normal in five of nine men with diabetic neuropathic impotence.

Entities:  

Mesh:

Year:  1988        PMID: 3342303     DOI: 10.1111/j.1464-410x.1988.tb09164.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

Review 1.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

2.  Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study.

Authors:  Shazli Azmi; Maryam Ferdousi; Uazman Alam; Ioannis N Petropoulos; Georgios Ponirakis; Andrew Marshall; Omar Asghar; Hassan Fadavi; Wendy Jones; Mitra Tavakoli; Andrew J M Boulton; Maria Jeziorska; Handrean Soran; Nathan Efron; Rayaz A Malik
Journal:  Diabetologia       Date:  2017-03-29       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.